Table 1 Burden of Chagas disease and screening of blood donors for T. cruzi in Latin America
From: Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries
Country | Estimated T. cruzi prevalence (%) [5] | Transmission by principal vector (year certified) [30] | Coverage of blood-donor screening (%) [29] | |
|---|---|---|---|---|
Argentina | 4.13–8.20 | Not interrupteda | 100 | 4.50 |
Belize | 0.74 | Interrupted | 100 | 0.40 |
Bolivia | 6.75–15.40 | Not interrupted | 86 | 9.90 |
Brazil | 0.80–1.30 | Not interrupteda | 100 | 0.61 |
Chile | 0.99–2.80 | Interrupted (1999) | 75b | 0.47 |
Colombia | 0.48–1.20 | Not interrupted | 99 | 2.80 |
Costa Rica | 0.53–11.70 | Interrupted | 99 | 0.98 |
Ecuador | 0.20–1.74 | Not interrupted | 100 | 0.15 |
El Salvador | 3.37–6.10 | Interrupted (2010) | 100 | 2.46 |
Guatemala | 1.98–7.89 | Interrupted (2009) | 100 | 0.79 |
Honduras | 3.05–5.80 | Interrupted (2011) | 100 | 1.40 |
Mexico | 0.50–6.80 | Not interrupteda | 100c | 1.50 |
Nicaragua | 1.14–1.70 | Interrupted (2011) | 100 | 0.49 |
Panama | 0.01–9.02 | Not interrupted | 98 | 0.90 |
Paraguay | 0.69–9.30 | Not interrupteda | 99 | 2.80 |
Peru | 0.20–3.00 | Not interrupteda | 99 | 0.26 |
Uruguay | 0.60–1.20 | Interrupted (1997) | 100 | 0.47 |
Venezuela | 1.16–4.00 | Not interrupted | 100 | 0.67 |